Global economic burden Of asbestos related diseases in comparison with the costs of production and consumption

Syed Mohamed Al-Junid Syed Junid, Ahmad Munir Qureshi, David Baguma

Research output: Contribution to journalArticle

Abstract

Occupational cancers, including mesothelioma and lung cancer are linked to the use of asbestos. Annually, at least 100,000 global deaths are attributed to asbestos exposure putting a heavy burden on national budgets. Expenses incurred on treatment of asbestos related diseases (ARDs) reduce households and national resource savings, while ARDs culminate in terminal burdens. The objective of this study is to measure the economic burden of ARDs and to assess the economic impact of asbestos consumption. The health and economic burden of asbestos was estimated in macro-global consumption-production model using production function frontier-based and generalized least squared approach for asbestos products and cost tabulation. Production, in metric tons (Mt) was adopted as a dependent variable among explanatory variables, including consumption. Information on treatment cost of asbestos related diseases (mesothelioma, asbestosis and lung cancer) was obtained from costing information and published literatures. Annual total economic burden of asbestos is at USD 11.92 billion. Out of this cost, USD 4.34 billion per annum is the economic burden of managing three common ARDs. The cost of compensation for patients suffering ARDs is USD 4.28 billion. From the remaining USD 3.3 billion, USD 2.93 billion is the value of asbestos consumed in 2003 and USD372.15 million is the loss of earning due to hospital visits and admissions. For every USD 1 spent on consumption of asbestos, global economy has to absorb almost USD 4 due to health consequences of ARDs. Banning of asbestos production and usage in production of goods has far-reaching impacts on household welfare, health and economic development. The insights revealed are expected to inform decision makers the need to ban all forms of asbestos, especially in developing countries where usage is increasing.

Original languageEnglish
Pages (from-to)111-125
Number of pages15
JournalMalaysian Journal of Public Health Medicine
Volume17
Issue number1
Publication statusPublished - 2017

Fingerprint

Asbestos
Economics
Costs and Cost Analysis
Mesothelioma
Lung Neoplasms
Health
Asbestosis
Economic Development
Budgets
Compensation and Redress

Keywords

  • Cost
  • Developing countries
  • Development
  • Lung cancer
  • Mesothelioma
  • Savings
  • Welfare

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Global economic burden Of asbestos related diseases in comparison with the costs of production and consumption. / Syed Junid, Syed Mohamed Al-Junid; Qureshi, Ahmad Munir; Baguma, David.

In: Malaysian Journal of Public Health Medicine, Vol. 17, No. 1, 2017, p. 111-125.

Research output: Contribution to journalArticle

@article{c8e3e2c06e4a4b778188a7b255b41812,
title = "Global economic burden Of asbestos related diseases in comparison with the costs of production and consumption",
abstract = "Occupational cancers, including mesothelioma and lung cancer are linked to the use of asbestos. Annually, at least 100,000 global deaths are attributed to asbestos exposure putting a heavy burden on national budgets. Expenses incurred on treatment of asbestos related diseases (ARDs) reduce households and national resource savings, while ARDs culminate in terminal burdens. The objective of this study is to measure the economic burden of ARDs and to assess the economic impact of asbestos consumption. The health and economic burden of asbestos was estimated in macro-global consumption-production model using production function frontier-based and generalized least squared approach for asbestos products and cost tabulation. Production, in metric tons (Mt) was adopted as a dependent variable among explanatory variables, including consumption. Information on treatment cost of asbestos related diseases (mesothelioma, asbestosis and lung cancer) was obtained from costing information and published literatures. Annual total economic burden of asbestos is at USD 11.92 billion. Out of this cost, USD 4.34 billion per annum is the economic burden of managing three common ARDs. The cost of compensation for patients suffering ARDs is USD 4.28 billion. From the remaining USD 3.3 billion, USD 2.93 billion is the value of asbestos consumed in 2003 and USD372.15 million is the loss of earning due to hospital visits and admissions. For every USD 1 spent on consumption of asbestos, global economy has to absorb almost USD 4 due to health consequences of ARDs. Banning of asbestos production and usage in production of goods has far-reaching impacts on household welfare, health and economic development. The insights revealed are expected to inform decision makers the need to ban all forms of asbestos, especially in developing countries where usage is increasing.",
keywords = "Cost, Developing countries, Development, Lung cancer, Mesothelioma, Savings, Welfare",
author = "{Syed Junid}, {Syed Mohamed Al-Junid} and Qureshi, {Ahmad Munir} and David Baguma",
year = "2017",
language = "English",
volume = "17",
pages = "111--125",
journal = "Malaysian Journal of Public Health Medicine",
issn = "1675-0306",
publisher = "Malaysian Public Health Physicians' Association",
number = "1",

}

TY - JOUR

T1 - Global economic burden Of asbestos related diseases in comparison with the costs of production and consumption

AU - Syed Junid, Syed Mohamed Al-Junid

AU - Qureshi, Ahmad Munir

AU - Baguma, David

PY - 2017

Y1 - 2017

N2 - Occupational cancers, including mesothelioma and lung cancer are linked to the use of asbestos. Annually, at least 100,000 global deaths are attributed to asbestos exposure putting a heavy burden on national budgets. Expenses incurred on treatment of asbestos related diseases (ARDs) reduce households and national resource savings, while ARDs culminate in terminal burdens. The objective of this study is to measure the economic burden of ARDs and to assess the economic impact of asbestos consumption. The health and economic burden of asbestos was estimated in macro-global consumption-production model using production function frontier-based and generalized least squared approach for asbestos products and cost tabulation. Production, in metric tons (Mt) was adopted as a dependent variable among explanatory variables, including consumption. Information on treatment cost of asbestos related diseases (mesothelioma, asbestosis and lung cancer) was obtained from costing information and published literatures. Annual total economic burden of asbestos is at USD 11.92 billion. Out of this cost, USD 4.34 billion per annum is the economic burden of managing three common ARDs. The cost of compensation for patients suffering ARDs is USD 4.28 billion. From the remaining USD 3.3 billion, USD 2.93 billion is the value of asbestos consumed in 2003 and USD372.15 million is the loss of earning due to hospital visits and admissions. For every USD 1 spent on consumption of asbestos, global economy has to absorb almost USD 4 due to health consequences of ARDs. Banning of asbestos production and usage in production of goods has far-reaching impacts on household welfare, health and economic development. The insights revealed are expected to inform decision makers the need to ban all forms of asbestos, especially in developing countries where usage is increasing.

AB - Occupational cancers, including mesothelioma and lung cancer are linked to the use of asbestos. Annually, at least 100,000 global deaths are attributed to asbestos exposure putting a heavy burden on national budgets. Expenses incurred on treatment of asbestos related diseases (ARDs) reduce households and national resource savings, while ARDs culminate in terminal burdens. The objective of this study is to measure the economic burden of ARDs and to assess the economic impact of asbestos consumption. The health and economic burden of asbestos was estimated in macro-global consumption-production model using production function frontier-based and generalized least squared approach for asbestos products and cost tabulation. Production, in metric tons (Mt) was adopted as a dependent variable among explanatory variables, including consumption. Information on treatment cost of asbestos related diseases (mesothelioma, asbestosis and lung cancer) was obtained from costing information and published literatures. Annual total economic burden of asbestos is at USD 11.92 billion. Out of this cost, USD 4.34 billion per annum is the economic burden of managing three common ARDs. The cost of compensation for patients suffering ARDs is USD 4.28 billion. From the remaining USD 3.3 billion, USD 2.93 billion is the value of asbestos consumed in 2003 and USD372.15 million is the loss of earning due to hospital visits and admissions. For every USD 1 spent on consumption of asbestos, global economy has to absorb almost USD 4 due to health consequences of ARDs. Banning of asbestos production and usage in production of goods has far-reaching impacts on household welfare, health and economic development. The insights revealed are expected to inform decision makers the need to ban all forms of asbestos, especially in developing countries where usage is increasing.

KW - Cost

KW - Developing countries

KW - Development

KW - Lung cancer

KW - Mesothelioma

KW - Savings

KW - Welfare

UR - http://www.scopus.com/inward/record.url?scp=85019477591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019477591&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85019477591

VL - 17

SP - 111

EP - 125

JO - Malaysian Journal of Public Health Medicine

JF - Malaysian Journal of Public Health Medicine

SN - 1675-0306

IS - 1

ER -